[OBSERVATIONS ON THE TOLERANCE TO NEUROLEPTICS IN MENTALLY DEFICIENT CHILDREN IN A SEMI-OPEN MILIEU].
D014150:Antipsychotic Agents; D002395:Catecholamines; D002648:Child; D004314:Down Syndrome; D006220:Haloperidol; D006801:Humans; D008607:Intellectual Disability; D008660:Metabolism; D008728:Methotrimeprazine; D019989:Persons with Intellectual Disabilities; D010640:Phenothiazines; D012701:Serotonin; D014116:Toxicology; D014149:Tranquilizing Agents; D014364:Tryptophan
D014150:Antipsychotic Agents; D002395:Catecholamines; D010640:Phenothiazines; D014149:Tranquilizing Agents; D012701:Serotonin; D014364:Tryptophan; D008728:Methotrimeprazine; D006220:Haloperidol; C084825:thioproperazine
CATECHOLAMINES; CHILD; HALOPERIDOL; MENTAL RETARDATION; METABOLISM; METHOTRIMEPRAZINE; MONGOLISM; SEROTONIN; THIOPROPERAZINE; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS; TRYPTOPHAN
OBSERVATIONS SUR LA TOL'ERANCE DES NEUROLEPTIQUES CHEZ DES ENFANTS D'EFICIENTS MENTAUX EN MILIEU SEMI-OUVERT.